zantac lawsuit Updates
Delaware Supreme Court Ruling Sets High Evidentiary Bar in Ranitidine Litigation
Delaware’s July 10 ruling, which aligns state Rule 702 with the federal Daubert standard, dramatically tightens the rules for admitting expert testimony in ranitidine cases. The decision overturns a trial court’s admissibility ruling and imposes strict evidentiary standards that many see as favoring defendants. The court criticized plaintiffs’ experts, like Dr. Sawyer, for lacking a direct scientific “bridge” between NDMA in ranitidine and cancer, effectively demanding evidence that may not yet exist. This ruling jeopardizes 75,000 Delaware cases and strengthens defense leverage nationwide, placing immense pressure on plaintiffs’ counsel to adapt or risk further trial losses.
Delaware Supreme Court Orders Re-Evaluation of Zantac Expert Testimony
The Delaware Supreme Court ruled that the trial judge overseeing the Zantac litigation applied an incorrect standard when admitting expert testimony linking ranitidine (Zantac) to cancer. The decision remands the case to Superior Court for rigorous scrutiny of the experts' reliability under established standards, echoing federal Daubert principles. Defendant pharmaceutical companies (GSK, Pfizer, Boehringer Ingelheim, Sanofi) argued the plaintiffs' experts were unreliable, a position previously adopted in the federal MDL but diverging from some state courts. While this ruling delays trials and is a significant setback, it does not dismiss the claims. Plaintiffs will now have the opportunity to present updated expert analyses, including data on ranitidine's breakdown into the carcinogen NDMA, seeking to meet the heightened scrutiny.
Boehringer Ingelheim Secures Defense Verdict in Illinois Zantac-Prostate Cancer Case
Boehringer Ingelheim obtained another defense verdict in Illinois state court this week. A jury rejected claims by a plaintiff alleging his prostate cancer resulted from seven years of using brand-name Zantac. This outcome aligns with the federal Multidistrict Litigation (MDL) Plaintiffs' Steering Committee's prior decision to cease pursuing prostate cancer claims. The committee halted these claims after scientific evidence supporting a causal link failed to withstand scrutiny. Recent verdicts, including this one, reinforce the scientific challenges associated with prostate cancer allegations in the ongoing Zantac litigation.
New Jersey Plaintiff Alleges Zantac Caused Multiple Cancers in Lawsuit Highlighting Latency Risks
A New Jersey man filed suit on June 2, 2025, alleging that 30 years of Zantac/ranitidine use (1990–2019) caused his prostate, kidney, and bladder cancers. The complaint claims manufacturers failed to warn that ranitidine breaks down into NDMA—a known carcinogen—and seeks damages for medical costs and suffering. This case underscores why Zantac litigation persists years after recalls: Cancers emerge decades after exposure due to NDMA’s latency period. Users with long-term consumption are only now diagnosing linked illnesses, ensuring new filings will continue as latent harms surface. The MDL (No. 2924) currently spans 100,000+ claims, with science increasingly validating causation theories.
About Zantac Lawsuit
For heartburn sufferers, Zantac seemed a blessing because of its effectiveness. However, in recent years, the once-popular heartburn medication has been linked to serious health risks.
For years, millions of people trusted Zantac to relieve their acid reflux and heartburn. Unfortunately, recent discoveries have shown that Zantac and other ranitidine products could contain dangerous levels of a cancer-causing chemical called NDMA. Without a doubt, the news is alarming because many people have used Zantac daily for years without ever realizing they were putting their health at risk.
Studies have revealed that NDMA in Zantac has a link to certain types of cancers, including stomach, liver, bladder, and pancreas.
Have you or a loved one recently developed a cancer that you believe is related to the long-term use of Zantac? If so, you are not alone, and you do have legal options, such as joining a class action lawsuit to seek compensation.
Who May Qualify In The Zantac Lawsuit?
Have you or a loved one used Zantac? If so, you may be eligible to participate in a Zantac class action lawsuit.
Do you meet the following criteria?
- You took Zantac or another ranitidine product regularly.
- You were diagnosed with cancer linked to NDMA exposure, such as bladder or stomach cancer.
- You can provide medical records showing your diagnosis and Zantac usage.
You may also qualify if you've been diagnosed with the following cancer(s).
- Liver Cancer
- Stomach/Gastric Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Bladder Cancer
- Intestinal (Not Colorectal)
Please note: You must have been diagnosed January 1st, 2000 - current year to potentially qualify. In addition, you must be a non-smoker and have used Zantac for a minimum of one year.
If you meet the above requirements, you may be entitled to compensation. We encourage you to seek legal advice to determine your eligibility. Various factors impact eligibility and all cases are unique.
Participating in a Zantac class action lawsuit could help you obtain monetary compensation to pay for your medical bills, pain, and suffering.
Which Companies Are Involved in the Zantac Lawsuits?
The makers of Zantac, including major pharmaceutical companies, are facing lawsuits. These companies are accused of failing to warn consumers about the risks of NDMA contamination in their products. Even after learning the risks of NDMA, the companies continued to market and sell Zantac even after the potential dangers became widely known.
As more information emerges, it is believed that the number of cases against these companies will grow by leaps and bounds. If you or someone you care about has been impacted by Zantac use, then you may have a case.
What Compensation Can You Expect in a Zantac Lawsuit?
The amount of compensation you might receive depends on a variety of factors, such as:
- The type and severity of your cancer.
- How long have you used Zantac?
- The evidence that links your cancer with Zantac use.
Currently, Zantac lawsuits remain in their infancy, and no major settlements have been reached. However, based on similar cases, compensation could be significant, especially for those who have suffered the most.
Has your health been impacted by Zantac use? If yes, do not hesitate. Reach out today to learn if you may qualify to participate in a Zantac lawsuit.
Add Comment